tiprankstipranks

David Schenkein Insider Profile

4 Followers
David Schenkein, Director at Agios Pharma, holds 472.71K shares in Agios Pharma (Ticker: AGIO), holds 72.99K shares in Denali Therapeutics (Ticker: DNLI), holds ― shares in Prime Medicine, Inc. (Ticker: PRME). Most recently, David Schenkein Sold ― shares of Agios Pharma on Feb 29, 2024 for an estimated value of 2.40M.
tipranks
David Schenkein

David Schenkein
Agios Pharma (AGIO)
Director

Ranked #68,349 out of 97,825 Corporate Insiders

Profitable Transactions

42%
8 out of 19 Profitable Transactions

Average Return

-5.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$16M
88.45%
9.74%
1.75%
0.06%
0.00% Others
A breakdown of David Schenkein's holdings

Insider Roles

Agios Pharma
(AGIO)
Director
Denali Therapeutics
(DNLI)
Director
Regeneron
(REGN)
Director
Bluebird Bio
(BLUE)
Director
+1 other positions
Roles that David Schenkein holds in companies

Most Profitable Insider Trade

Stock:
Agios Pharma
(AGIO)
Rating:Informative Buy
Date:Mar 27, 2014 - Mar 27, 2015
Return:+164.20%
The most profitable trade made by David Schenkein

David Schenkein's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Agios Pharma
Feb 29, 2024
Director
Informative Sell
2.40M
$13.77M
Denali Therapeutics
Jun 05, 2023
Director
Uninformative Buy
$1.52M
Prime Medicine, Inc.
Director
Regeneron
Jan 04, 2024
Director
Uninformative Buy
$272.50K
FMI
Foundation Medicine
Jun 20, 2016
Uninformative Buy
240.65K
$2.98M
Bluebird Bio
Jun 22, 2020
Director
Uninformative Buy
$9.33K
List of latest transactions for each holding click on a transaction to see David Schenkein's performance on stock

David Schenkein insider profile FAQ

What is the percentage of profitable transactions made by David Schenkein?
The percentage of profitable transactions made by David Schenkein is 42%.
    What is the average return per transaction made by David Schenkein?
    The average return per transaction made by David Schenkein is -5.40%.
      What stocks does David Schenkein hold?
      David Schenkein holds: AGIO, DNLI, PRME, REGN, FMI, BLUE stocks.
        What was David Schenkein’s latest transaction?
        David Schenkein latest transaction was an Informative Sell of $2.40M.
          What was David Schenkein's most profitable transaction?
          David Schenkein’s most profitable transaction was an Informative Buy of AGIO stock on March 27, 2014. The return on the trade was 164.20%.
            What is David Schenkein's role in Agios Pharma?
            David Schenkein's role in Agios Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.